Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2021 | 3 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency.
Nat Commun. 2023 Aug 18;14(1):5032. doi: 10.1038/s41467-023-40758-0.
Nat Commun. 2023.
PMID: 37596280
Free PMC article.
Clinical Trial.
Platelet-expressed immune checkpoint regulator GITRL in breast cancer.
Zhou Y, Heitmann JS, Clar KL, Kropp KN, Hinterleitner M, Engler T, Koch A, Hartkopf AD, Zender L, Salih HR, Maurer S, Hinterleitner C.
Zhou Y, et al. Among authors: clar kl.
Cancer Immunol Immunother. 2021 Sep;70(9):2483-2496. doi: 10.1007/s00262-021-02866-y. Epub 2021 Feb 4.
Cancer Immunol Immunother. 2021.
PMID: 33538861
Free PMC article.
Item in Clipboard
Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression.
Rittig SM, Lutz MS, Clar KL, Zhou Y, Kropp KN, Koch A, Hartkopf AD, Hinterleitner M, Zender L, Salih HR, Maurer S, Hinterleitner C.
Rittig SM, et al. Among authors: clar kl.
Front Oncol. 2022 Jul 8;12:917834. doi: 10.3389/fonc.2022.917834. eCollection 2022.
Front Oncol. 2022.
PMID: 35875148
Free PMC article.
Item in Clipboard
Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL.
Clar KL, Hinterleitner C, Schneider P, Salih HR, Maurer S.
Clar KL, et al.
Cancers (Basel). 2019 Feb 26;11(3):277. doi: 10.3390/cancers11030277.
Cancers (Basel). 2019.
PMID: 30813611
Free PMC article.
Item in Clipboard
Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas.
Hagelstein I, Lutz MS, Schmidt M, Heitmann JS, Malenke E, Zhou Y, Clar KL, Kopp HG, Jung G, Salih HR, Märklin M, Hinterleitner C.
Hagelstein I, et al. Among authors: clar kl.
Front Immunol. 2021 Apr 14;12:653081. doi: 10.3389/fimmu.2021.653081. eCollection 2021.
Front Immunol. 2021.
PMID: 33936075
Free PMC article.
Item in Clipboard
Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course.
Clar KL, Weber LM, Schmied BJ, Heitmann JS, Marconato M, Tandler C, Schneider P, Salih HR.
Clar KL, et al.
Cancers (Basel). 2021 Dec 4;13(23):6122. doi: 10.3390/cancers13236122.
Cancers (Basel). 2021.
PMID: 34885231
Free PMC article.
Item in Clipboard
The novel deubiquitinase inhibitor b-AP15 induces direct and NK cell-mediated antitumor effects in human mantle cell lymphoma.
Kropp KN, Maurer S, Rothfelder K, Schmied BJ, Clar KL, Schmidt M, Strunz B, Kopp HG, Steinle A, Grünebach F, Rittig SM, Salih HR, Dörfel D.
Kropp KN, et al. Among authors: clar kl.
Cancer Immunol Immunother. 2018 Jun;67(6):935-947. doi: 10.1007/s00262-018-2151-y. Epub 2018 Mar 19.
Cancer Immunol Immunother. 2018.
PMID: 29556699
Item in Clipboard
Cite
Cite